Skip to main content
HLF
NYSE Trade & Services

Herbalife Exceeds Q1 Guidance, Raises Full-Year Outlook, and Secures $45M Annual Interest Savings from Refinancing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$15.95
Mkt Cap
$1.7B
52W Low
$6.59
52W High
$20.4
52W Position info
142% above low
Off High info
22% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

HLF has more than doubled off its 52-week low of $6.59.

Summary

Herbalife reported Q1 results above guidance, raised its full-year outlook, and expects $45 million in annual interest savings from a recent debt refinancing, alongside a strategic acquisition.


Key Events · Earnings and Guidance · HLF

  • Exceeded Q1 Financial Guidance

    Herbalife reported first-quarter 2026 net sales of $1.3 billion, up 7.8% year-over-year (5.4% on a constant currency basis), and adjusted EBITDA of $175.7 million, both exceeding the company's guidance.

  • Raised Full-Year 2026 Guidance

    The company revised its full-year 2026 guidance, narrowing the net sales and adjusted EBITDA ranges and increasing the constant currency midpoints, reflecting a more optimistic outlook.

  • Completed Debt Refinancing with Significant Savings

    Herbalife completed a $1.45 billion senior secured debt refinancing on April 29, which is expected to result in approximately $45 million in annual cash interest savings and reduced total leverage ratio to 2.7x.

  • Strategic Acquisition of Bioniq Assets

    On April 30, Herbalife acquired substantially all of the assets of Bioniq's core personalized nutrition business for $55 million in base consideration, expanding its personalized nutrition offerings.


Analysis · HLF · Trade & Services

Herbalife Ltd. reported strong first-quarter 2026 financial results that surpassed its own guidance, driven by robust net sales and adjusted EBITDA. The company also raised the midpoints of its full-year 2026 net sales and adjusted EBITDA guidance, signaling improved future performance. Furthermore, the recently completed $1.45 billion debt refinancing is expected to generate approximately $45 million in annual cash interest savings, significantly enhancing the company's financial flexibility and profitability. The acquisition of Bioniq's personalized nutrition business also strengthens Herbalife's strategic position in a key growth area. These combined factors present a positive outlook for investors.

At the time of this filing, HLF was trading at $15.95 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $6.59 to $20.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HLF - Latest Insights

HLF
Aug 05, 2026, 4:39 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.60
Real-time Price: $11.71 info
Change: -$0.890 (-7%) info
Market Cap: $1.206B info
HLF
Aug 05, 2026, 4:24 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $12.60
Real-time Price: $11.71 info
Change: -$0.890 (-7%) info
Market Cap: $1.206B info
HLF
May 20, 2026, 8:50 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $12.57
Real-time Price: $11.71 info
Change: -$0.860 (-7%) info
Market Cap: $1.206B info
HLF
May 12, 2026, 9:59 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $13.63
Real-time Price: $11.71 info
Change: -$1.92 (-14%) info
Market Cap: $1.206B info
HLF
May 12, 2026, 4:50 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $13.63
Real-time Price: $11.71 info
Change: -$1.92 (-14%) info
Market Cap: $1.206B info